Radiation Oncology

Article	Citations
Radiotherapy and the gut microbiome: facts and fiction	106
Current status and recent advances in reirradiation of glioblastoma	104
Risk factors for osteoradionecrosis of the jaw in patients with head and neck squamous cell carcinoma	83
Radiation-induced kidney toxicity: molecular and cellular pathogenesis	73
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations	67
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers	47
Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review	45
Deep learning method for prediction of patient-specific dose distribution in breast cancer	43
Radiotherapy of oligometastatic prostate cancer: a systematic review	41
The watch-and-wait strategy versus surgical resection for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy	41
Feasibility of Conebeam CT-based online adaptive radiotherapy for neoadjuvant treatment of rectal cancer	38
Clinical feasibility of deep learning-based auto-segmentation of target volumes and organs-at-risk in breast cancer patients after breast-conserving surgery	36
Interobserver variability in organ at risk delineation in head and neck cancer	36
Current status and recent advances in resection cavity irradiation of brain metastases	35
The basis and advances in clinical application of boron neutron capture therapy	34
Radiation-induced senescence: therapeutic opportunities	31
Evaluation of a treatment planning system developed for clinical boron neutron capture therapy and validation against an independent Monte Carlo dose calculation system	31
Radiosensitization of breast cancer cells using AS1411 aptamer-conjugated gold nanoparticles	31
Benefit of replanning in MR-guided online adaptive radiation therapy in the treatment of liver metastasis	30
Generating synthetic CT from low-dose cone-beam CT by using generative adversarial networks for adaptive radiotherapy	29
68Ga-DOTATATE PET-CT as a tool for radiation planning and evaluating treatment responses in the clinical management of meningiomas	29
Dosimetric benefit of MR-guided online adaptive radiotherapy in different tumor entities: liver, lung, abdominal lymph nodes, pancreas and prostate	28
Clinical validation of a commercially available deep learning software for synthetic CT generation for brain	28
Adjuvant radiotherapy versus observation following gross total resection for atypical meningioma: a systematic review and meta-analysis	28
Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells	28

A review of radiomics and genomics applications in cancers: the way towards precision medicine	28
Patient positioning and immobilization procedures for hybrid MR-Linac systems	27
Delta radiomics analysis of Magnetic Resonance guided radiotherapy imaging data can enable treatment response prediction in pancreatic cancer	27
Radiotherapy modulates tumor cell fate decisions: a review	26
Development and validation of a radiomics-based model to predict local progression-free survival after chemo-radiotherapy in patients with esophageal squamous cell cancer	26
Evaluation of auto-segmentation accuracy of cloud-based artificial intelligence and atlas-based models	25
Developing an accurate model of spot-scanning treatment delivery time and sequence for a compact superconducting synchrocyclotron proton therapy system	25
Explainable AI for CNN-based prostate tumor segmentation in multi-parametric MRI correlated to whole mount histopathology	25
The roles of CC chemokines in response to radiation	25
FET-PET radiomics in recurrent glioblastoma: prognostic value for outcome after re-irradiation?	25
Deep-inspirational breath-hold (DIBH) technique in left-sided breast cancer: various aspects of clinical utility	25
The impact of pelvic radiotherapy on the gut microbiome and its role in radiation-induced diarrhoea: a systematic review	24
Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer	23
Evaluation of deep learning-based autosegmentation in breast cancer radiotherapy	23
Real-time liver tracking algorithm based on LSTM and SVR networks for use in surface-guided radiation therapy	22
Accelerated coronary calcium burden in breast cancer patients after radiotherapy: a comparison with age and race matched healthy women	21
Clinical features, treatment and outcomes in patients with tracheal adenoid cystic carcinoma: a systematic literature review	21
Machine learning models predict overall survival and progression free survival of non-surgical esophageal cancer patients with chemoradiotherapy based on CT image radiomics signatures	21
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer	21
Metastasis directed stereotactic radiotherapy in NSCLC patients progressing under targeted- or immunotherapy: efficacy and safety reporting from the ‘TOaSTT’ database	21
Risk factors for radiation pneumonitis in lung cancer patients with subclinical interstitial lung disease after thoracic radiation therapy	20
MR-guided adaptive versus ITV-based stereotactic body radiotherapy for hepatic metastases (MAESTRO): a randomized controlled phase II trial	20
Combining losartan with radiotherapy increases tumor control and inhibits lung metastases from a HER2/neu-positive orthotopic breast cancer model	20
Outcomes of metastasis-directed therapy of bone oligometastatic prostate cancer	19
Review of cone beam computed tomography based online adaptive radiotherapy: current trend and future direction	19
Dosimetric study between a single isocenter dynamic conformal arc therapy technique and Gamma Knife radiosurgery for multiple brain metastases treatment: impact of target volume geometrical characteri	19
The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering	19
Clinical implementation of magnetic resonance imaging simulation for radiation oncology planning: 5 year experience	19
MR-guided SBRT boost for patients with locally advanced or recurrent gynecological cancers ineligible for brachytherapy: feasibility and early clinical experience	18
Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients	18
Effect of intrafraction adaptation on PTV margins for MRI guided online adaptive radiotherapy for rectal cancer	18
Technical assessment of the NDI Polaris Vega optical tracking system	18
Prognostic value of tumor measurement parameters and SCC-Ag changes in patients with locally-advanced cervical cancer	18
The dosimetric impact of deep learning-based auto-segmentation of organs at risk on nasopharyngeal and rectal cancer	18
Preoperative hypofractionated radiotherapy for soft tissue sarcomas: a systematic review	18
Radiation pneumonitis in patients with non-small-cell lung cancer receiving chemoradiotherapy and an immune checkpoint inhibitor: a retrospective study	18
MR-guided stereotactic body radiation therapy for primary cardiac sarcomas	17
A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer	17
Therapeutic outcome and related predictors of stereotactic body radiotherapy for small liver-confined HCC: a systematic review and meta-analysis of observational studies	17
Dosimetric impact of deep learning-based CT auto-segmentation on radiation therapy treatment planning for prostate cancer	17
Radiomics for prediction of radiation-induced lung injury and oncologic outcome after robotic stereotactic body radiotherapy of lung cancer: results from two independent institutions	16
Oligometastatic head and neck cancer: Which patients benefit from radical local treatment of all tumour sites?	16
Comparing biological effectiveness guided plan optimization strategies for cranial proton therapy: potential and challenges	16
Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer	16
Dosimetric analysis of local failures in skull-base chordoma and chondrosarcoma following pencil beam scanning proton therapy	15
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems	15
Axitinib in combination with radiotherapy for advanced hepatocellular carcinoma: a phase I clinical trial	15
Overlap time is an independent risk factor of radiation pneumonitis for patients treated with simultaneous EGFR-TKI and thoracic radiotherapy	15
Deep learning in CT image segmentation of cervical cancer: a systematic review and meta-analysis	15
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group	15

Radiation pneumonitis prediction after stereotactic body radiation therapy based on 3D dose distribution: dosiomics and/or deep learning-based radiomics features	14
Applicability of a pathological complete response magnetic resonance-based radiomics model for locally advanced rectal cancer in intercontinental cohort	14
Outcomes and prognostic factors in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy	14
Sintilimab, stereotactic body radiotherapy and granulocyte–macrophage colony stimulating factor as second-line therapy for advanced non-small cell lung cancer: safety run-in results of a multicenter,	14
The first reported case of a patient with pancreatic cancer treated with cone beam computed tomography-guided stereotactic adaptive radiotherapy (CT-STAR)	14
Role of stereotactic body radiation in the enhancement of the quality of life in locally advanced pancreatic adenocarcinoma: a systematic review	14
Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study	14
A clinical study of curative partial breast irradiation for stage I breast cancer using carbon ion radiotherapy	14
Surgical spacer placement for proton radiotherapy in locally advanced pancreatic body and tail cancers: initial clinical results	14
A prospective study investigating the efficacy and toxicity of definitive ChemoRadiation and ImmunOtherapy (CRIO) in locally and/or regionally advanced unresectable cutaneous squamous cell carcinoma	14
Pediatric craniospinal irradiation with a short partial-arc VMAT technique for medulloblastoma tumors in dosimetric comparison	13
Multifocal high-grade glioma radiotherapy safety and efficacy	13
Magnetic resonance guided adaptive stereotactic body radiotherapy for lung tumors in ultracentral location: the MAGELLAN trial (ARO 2021-3)	13
A deep image-to-image network organ segmentation algorithm for radiation treatment planning: principles and evaluation	13
Clinical application of MR-Linac in tumor radiotherapy: a systematic review	13
Medical student education through flipped learning and virtual rotations in radiation oncology during the COVID-19 pandemic: a cross sectional research	13
Clinical outcome and pathologic correlation of stereotactic body radiation therapy as a bridge to transplantation for advanced hepatocellular carcinoma: a case series	13
Efficacy and safety of carbon ion radiotherapy for bone sarcomas: a systematic review and meta-analysis	13
Stereotactic MRI-guided radiation therapy for localized prostate cancer (SMILE): a prospective, multicentric phase-II-trial	13
Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma	13
CT radiomics-based long-term survival prediction for locally advanced non-small cell lung cancer patients treated with concurrent chemoradiotherapy using features from tumor and tumor organismal envir	13
Proton therapy with a fixed beamline for skull-base chordomas and chondrosarcomas: outcomes and toxicity	13
Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study	13
Simultaneous radiosurgery for multiple brain metastases: technical overview of the UCLA experience	13
Treatment planning comparison of volumetric modulated arc therapy with the trilogy and the Halcyon for bilateral breast cancer	12
Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer	12
Outcome of early stage Merkel carcinoma treated by exclusive radiation: a study of 53 patients	12
Interfractional target changes in brain metastases during 13-fraction stereotactic radiotherapy	12
Apparent diffusion coefficient for the prediction of tumor response to neoadjuvant chemo-radiotherapy in locally advanced rectal cancer	12
Salvage re-irradiation using stereotactic body radiation therapy for locally recurrent prostate cancer: the impact of castration sensitivity on treatment outcomes	12
Report on planning comparison of VMAT, IMRT and helical tomotherapy for the ESCALOX-trial pre-study	12
Lung stereotactic body radiation therapy for elderly patients aged ≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study	12
Operating procedures, risk management and challenges during implementation of adaptive and non-adaptive MR-guided radiotherapy: 1-year single-center experience	12
Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer	12
Chemoradiotherapy for limited-stage small-cell lung cancer and interstitial lung abnormalities	11
Durvalumab (MEDI 4736) in combination with extended neoadjuvant regimens in rectal cancer: a study protocol of a randomised phase II trial (PRIME-RT)	11
Clinical outcomes of extensive-stage small cell lung cancer patients treated with thoracic radiotherapy at different times and fractionations	11
Therapeutic effect of osimertinib plus cranial radiotherapy compared to osimertinib alone in NSCLC patients with EGFR-activating mutations and brain metastases: a retrospective study	11
Stereotactic body radiotherapy versus conventional radiotherapy for painful bone metastases: a systematic review and meta-analysis of randomised controlled trials	11
MR-guided radiotherapy in node-positive non-small cell lung cancer and severely limited pulmonary reserve: a report proposing a new clinical pathway for the management of high-risk patients	11
Biological dosiomic features for the prediction of radiation pneumonitis in esophageal cancer patients	11
Diffusion-weighted MRI and 18F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma	11
High dose simultaneous integrated boost for node positive cervical cancer	11
Organs-at-risk dose constraints in head and neck intensity-modulated radiation therapy using a dataset from a multi-institutional clinical trial (JCOG1015A1)	11
Pattern of failure in prostate cancer previously treated with radical prostatectomy and post-operative radiotherapy: a secondary analysis of two prospective studies using novel molecular imaging techn	11
Stereotactic ablative body radiotherapy boost for cervical cancer when brachytherapy boost is not feasible	11
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy	11
Stereotactic body radiotherapy extends the clinical benefit of PD-1 inhibitors in refractory recurrent/metastatic nasopharyngeal carcinoma	11
A deep learning-based self-adapting ensemble method for segmentation in gynecological brachytherapy	10
Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer	10
Complete response to neoadjuvant chemoradiotherapy in rectal cancer is associated with RAS/AKT mutations and high tumour mutational burden	10
Long-term outcome after combined kyphoplasty and intraoperative radiotherapy (Kypho-IORT) for vertebral tumors	10
A meta-analysis of the efficacy and safety of accelerated partial breast irradiation versus whole-breast irradiation for early-stage breast cancer	10
Intrafractional stability of MR-guided online adaptive SBRT for prostate cancer	10
Whole-brain irradiation differentially modifies neurotransmitters levels and receptors in the hypothalamus and the prefrontal cortex	10
RBE-weighted dose conversions for patients with recurrent nasopharyngeal carcinoma receiving carbon-ion radiotherapy from the local effect model to the microdosimetric kinetic model	10
MR-guided adaptive stereotactic body radiotherapy (SBRT) of primary tumor for pain control in metastatic pancreatic ductal adenocarcinoma (mPDAC): an open randomized, multicentric, parallel group clin	10
The decreased mean platelet volume is associated with poor prognosis in patients with oropharyngeal cancer treated with radiotherapy	10
Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy	10
Geometric and dosimetric impact of 3D generative adversarial network-based metal artifact reduction algorithm on VMAT and IMPT for the head and neck region	10
Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up p	10
Stereotactic body radiotherapy in combination with non-frontline PD-1 inhibitors and targeted agents in metastatic renal cell carcinoma	9
Omitting surgery in esophageal cancer patients with complete response after neoadjuvant chemoradiotherapy: a systematic review and meta-analysis	9
Differential effects of radiation fractionation regimens on glioblastoma	9
Deep learning-based automatic delineation of the hippocampus by MRI: geometric and dosimetric evaluation	9
Effects of whole-brain radiation therapy on the blood–brain barrier in immunocompetent and immunocompromised mouse models	9
Outcome of intracerebral cavernoma treated by Gamma Knife radiosurgery based on a double-blind assessment of treatment indication	9
Topographic distribution of lymph node metastasis in patients with stage IB1 cervical cancer: an analysis of 8314 lymph nodes	9
Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials	9
Simultaneous integrated boost concepts in definitive radiation therapy for esophageal cancer: outcomes and toxicity	9
Clinical predictors of pathological good response in locally advanced rectal cancer	9
Unplanned hospitalizations in patients with locoregionally advanced head and neck cancer treated with (chemo)radiotherapy with and without prophylactic percutaneous endoscopic gastrostomy	9
Predicting survival in anaplastic astrocytoma patients in a single-center cohort of 108 patients	9
Treatment outcome and compliance to dose-intensified linac-based SBRT for unfavorable prostate tumors using a novel real-time organ-motion tracking	9
Radiosurgery of limited brain metastases from primary solid tumor: results of the randomized phase III trial (NCT02355613) comparing treatments executed with a specialized or a C-arm linac-based platf	9
Predictors of osteoradionecrosis following irradiated tooth extraction	9
Long-term outcomes of SBRT for PSMA PET detected oligometastatic prostate cancer	8
Personalising treatment plan quality review with knowledge-based planning in the TROG 15.03 trial for stereotactic ablative body radiotherapy in primary kidney cancer	8
Molecular features of glioblastomas in long-term survivors compared to short-term survivors—a matched-pair analysis	8
Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT	8

Investigation of the clinical inter-observer bias in prostate fiducial marker image registration between CT and MR images	8
Cranial organs at risk delineation: heterogenous practices in radiotherapy planning	8
Gastrointestinal and genitourinary toxicity profiles of metformin versus placebo in men with prostate cancer receiving prostate radiotherapy: interim toxicity results of a double-blinded, multicenter,	8
A dual deep neural network for auto-delineation in cervical cancer radiotherapy with clinical validation	8
Strategies to improve deep learning-based salivary gland segmentation	8
Validation of an MRI-only planning workflow for definitive pelvic radiotherapy	8
Stratified assessment of an FDA-cleared deep learning algorithm for automated detection and contouring of metastatic brain tumors in stereotactic radiosurgery	8
Efficacy and safety of radiotherapy plus anti-PD1 versus transcatheter arterial chemoembolization plus sorafenib for advanced hepatocellular carcinoma: a real-world study	8
Phase II study of stereotactic body radiotherapy with hydrogel spacer for prostate cancer: acute toxicity and propensity score-matched comparison	8
Stereotactic body radiation therapy for the treatment of localized prostate cancer in men with underlying inflammatory bowel disease	8
Automatic segmentation of vestibular schwannomas from T1-weighted MRI with a deep neural network	8
Stereotactic radiosurgery for treating meningiomas eligible for complete resection	8
Benefit of chemotherapy based on platinum with definitive radiotherapy in older patients with locally advanced esophageal squamous cell carcinoma	8
Prognostic value of tumor-infiltrating immune cells and immune checkpoints in elderly head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiotherapy	8
Synthetic contrast-enhanced computed tomography generation using a deep convolutional neural network for cardiac substructure delineation in breast cancer radiation therapy: a feasibility study	8
Radiotherapeutic treatment options for oligotopic malignant liver lesions	8
Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy	8
Clinical utility of Gafchromic film in an MRI-guided linear accelerator	8
A cycle generative adversarial network for improving the quality of four-dimensional cone-beam computed tomography images	8
Applications of various range shifters for proton pencil beam scanning radiotherapy	8
Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution	8
Patterns of nodal spread in stage III NSCLC: importance of EBUS-TBNA and 18F-FDG PET/CT for radiotherapy target volume definition	8
Variability of α/β ratios for prostate cancer with the fractionation schedule: caution against using the linear-quadratic model for hypofractionated radiotherapy	8
An interpretable radiomics model to select patients for radiotherapy after surgery for WHO grade 2 meningiomas	8
Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study	8
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China	8
Clinical evaluation of two AI models for automated breast cancer plan generation	8
Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia	8
Imaging biomarkers of contrast-enhanced computed tomography predict survival in oesophageal cancer after definitive concurrent chemoradiotherapy	8
Stereotactic radiosurgery of benign brain tumors in elderly patients: evaluation of outcome and toxicity	7
Association of neutrophil-to-lymphocyte ratio, radiotherapy fractionation/technique, and risk of development of distant metastasis among patients with locally advanced rectal cancer	7
Ventilation and perfusion MRI at a 0.35 T MR-Linac: feasibility and reproducibility study	7
Delayed postoperative radiotherapy increases the incidence of radiographic local tumor progression before radiotherapy and leads to poor prognosis in spinal metastases	7
Postoperative locoregional recurrence pattern and treatment management of stage pT4 sigmoid colon cancer: a retrospective cohort study	7
Quality assurance of radiotherapy in the ongoing EORTC 1420 “Best of” trial for early stage oropharyngeal, supraglottic and hypopharyngeal carcinoma: results of the benchmark case procedure	7
Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study	7
Transparency in quality of radiotherapy for breast cancer in the Netherlands: a national registration of radiotherapy-parameters	7
Combined effect of dose gradient and rotational error on prescribed dose coverage for single isocenter multiple brain metastases in frameless stereotactic radiotherapy	7
Assessing radiation-induced carotid vasculopathy using ultrasound after unilateral irradiation: a cross-sectional study	7
Selectively recommend 18F-FDG PET/CT for patients with de novo nasopharyngeal carcinoma in endemic areas	7
Long-term outcome of stereotactic brachytherapy with temporary Iodine-125 seeds in patients with WHO grade II gliomas	7
Radiotherapy dose–volume parameters predict facial lymphedema after concurrent chemoradiation for nasopharyngeal carcinoma	7
Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory	7
The relationship between the radiation dose of pelvic-bone marrow and lymphocytic toxicity in concurrent chemoradiotherapy for cervical cancer	7
Technical note: factors affecting dose distribution in the overlap region of two-segment total body irradiation by helical tomotherapy	7
External application of liver compresses to reduce fatigue in patients with metastatic cancer undergoing radiation therapy, a randomized clinical trial	7
True abscopal effect in a patient with metastatic non-small cell lung cancer	7
Intra-fraction displacement of the prostate bed during post-prostatectomy radiotherapy	7
Factors associated with long-term survival in gemcitabine-concurrent proton radiotherapy for non-metastatic locally advanced pancreatic cancer: a single-center retrospective study	7
Cancer care at the time of the fourth industrial revolution: an insight to healthcare professionals’ perspectives on cancer care and artificial intelligence	7
Appropriate margin for planning target volume for breast radiotherapy during deep inspiration breath-hold by variance component analysis	7
Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?	7
Concurrent chemoradiotherapy with S-1 compared with concurrent chemoradiotherapy with docetaxel and cisplatin for locally advanced esophageal squamous cell carcinoma	7
Vertebral body and splenic irradiation are associated with lymphopenia in localized pancreatic cancer treated with stereotactic body radiation therapy	7
Glioblastoma radiotherapy using Intensity modulated Radiotherapy (IMRT) or proton Radiotherapy—GRIPS Trial (Glioblastoma Radiotherapy via IMRT or Proton BeamS): a study protocol for a multicenter, pro	7
Hypofractionated intensity-modulated radiotherapy with concurrent chemotherapy for elderly patients with locally advanced pancreatic carcinoma	7
Developing and validating an integrated gross tumor volume (GTV)-TNM stratification system for supplementing unresectable locally advanced non-small cell lung cancer treated with concurrent chemoradio	7
Efficacy of concurrent chemoradiotherapy in subgroups of stage III nasopharyngeal carcinoma: an analysis based on 10-year follow-up	7
Estimating the tolerance of brachial plexus to hypofractionated stereotactic body radiotherapy: a modelling-based approach from clinical experience	7
Preoperative spirometry and BMI in deep inspiration breath-hold radiotherapy: the early detection of cardiac and lung dose predictors without radiation exposure	7
Improving the efficacy of combined radiotherapy and immunotherapy: focusing on the effects of radiosensitivity	7
Determining optimal clinical target volume margins in high-grade glioma based on microscopic tumor extension and magnetic resonance imaging	7
Role of postoperative radiotherapy in resected adenoid cystic carcinoma of the head and neck	7
Cardiac-sparing radiotherapy for locally advanced non-small cell lung cancer	7
Adjuvant therapy for retroperitoneal sarcoma: a meta-analysis	7